1. Stryker is selling its U.S. spinal implant business to Viscogliosi Brothers. Stryker also reported $6.4 billion in net sales during the fourth quarter of 2024.
2. Neuralink enlisted The Miami Project to Cure Paralysis and the Department of Neurological Surgery at the University of Miami (Fla.) Miller School of Medicine as the second site of its PRIME study.
3. NuVasive and orthopedic devicemaker SMAIO mutually decided to end their software co-development efforts.
4. Saluda Medical earned FDA approval for its biomarker-based automated patient programming platform used in spinal cord stimulation.
5. Centinel Spine saw prodisc revenue surpass $95 million in 2024.
6. Aurora Spine promoted two executive leaders. Matt Paxton was named executive vice president of sales, and Katelyn Sims is now area vice president of commercialization and key accounts.
7. Zimmer Biomet acquired orthopedic company Paragon 28.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
